Either a CD4+ or CD8+ T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice

Microbial Pathogenesis

Volumn 27, Issue 6, 1999, Pages 387-394

  Ghiasi, Homayon ^a,b   Perng, Guey Chuen ^a   Nesburn, Anthony B ^a,b   Wechsler, Steven L ^a,b  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic infection; HSV 1; Latency; Ocular; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EYE INFECTION; HERPES SIMPLEX VIRUS 1; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRIGEMINUS GANGLION; VIRUS INFECTIVITY;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; MUS MUSCULUS;

EID: 0033405453     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1999.0314     Document Type: Article

References (37)

1. Corey L, Whitley RJ, Stone EF, Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet. 1:1988;1-4.
2. Whitley RJ. Herpes simplex virus infections of women and their offspring: implications for a developed society. Virology. 200:1994;220-235.
3. Dawson CR. Ocular herpes simplex virus infections. Clin Dermatol. 2:1984;56-66.
4. Wechsler SL, Nesburn AB, Watson R, Slanina SM, Ghiasi H. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J Virol. 62:1988;4051-4058.
5. Cook ML, Bastone VB, Stevens JG. Evidence that neurons harbor latent herpes simplex virus. Infect Immun. 9:1974;946-951.
6. Jordan MC, Jordan GW, Stevens JG, Miller G. Latent herpes viruses of humans. Ann Intern Med. 100:1984;866-880.
7. Stevens JG. Latent herpes simplex virus and the nervous system. Curr Top Microbiol Immunol. 70:1975;31-50.
8. Rock DL, Fraser NW. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature. 302:1983;523-525.
9. Fraser NW, Block TM, Spivack JG. The latency-associated transcripts of herpes simplex virus: RNA in search of function. Virology. 191:1992;1-8.
10. Rock DL, Nesburn AB, Ghiasi H, Ong J, Lewis TL, Lokensgard JR, Wechsler SL. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J Virol. 61:1987;3820-3826.
11. Daheshia M, Feldman LT, Rouse BT. Herpes simplex virus latency and the immune response. Curr Opin Microbiol. 1:1998;430-435.
12. Valyi-Nagy T, Deshmane SL, Raengsakulrach B, Nicosia M, Gesser RM, Wysocka M, Dillner A, Fraser NW. Herpes simplex virus type 1 mutant strain in 1814 establishes a unique, slowly progressing infection in SCID mice. J Virol. 66:1992;7336-7345.
13. Grusby MJ, Auchincloss H Jr, Lee R, Johnson RS, Spencer JP, Zijlstra M, Jaenisch R, Papaioannou VE, Glimcher LH. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci USA. 90:1993;3913-3917.
14. Gordon YJ, Rock DL. Co-cultivation versus blot hybridization for the detection of trigeminal ganglionic latency following corneal inoculation with HSV-1 strains of varying TK expression and pathogenicity. Curr Eye Res. 3:1984;1097-1100.
15. Ghiasi H, Cai S, Nesburn AB, Wechsler SL. Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection. Virology. 224:1996;330-333.
16. Autenrieth IB, Hantschmann P, Heymer B, Heesemann J. Immunohistological characterization of the cellular immune response against Yersinia enterocolitica in mice: evidence for the involvement of T lymphocytes. Immunobiology. 187:1993;1-16.
17. Rahemtulla A, Fung-Leung WP, Schilham MW, Kundig TM, Sambhara SR, Narendran A, Arabian A, Wakeham A, Paige CJ, Zinkernagel RM et al. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature. 353:1991;180-184.
18. Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, Mathis D. Mice lacking MHC class II molecules. Cell. 66:1991;1051-1066.
19. Fung-Leung WP, Schilham MW, Rahemtulla A, Kundig TM, Vollenweider M, Potter J, van Ewijk W, Mak TW. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell. 65:1991;443-449.
20. Koller BH, Smithies O. Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc Natl Acad Sci USA. 86:1989;8932-8935.
21. Wechsler SL, Nesburn AB, Watson R, Slanina S, Ghiasi H. Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J Gen Virol. 69:1988;3101-3106.
22. Ghiasi H, Wechsler SL, Cai S, Nesburn AB, Hofman FM. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology. 95:1998;352-359.
23. Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol. 68:1994;2118-2126.
24. Ghiasi H, Nesburn AB, Wechsler SL. Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein. Vaccine. 14:1996;107-112.
25. Ghiasi H, Cai S, Nesburn AB, Wechsler SL. MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1. Curr Eye Res. 16:1997;1152-1158.
26. Ghiasi H, Roopenian DC, Slanina S, Cai S, Nesburn AB, Wechsler SL. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge. Immunology. 91:1997;430-435.
27. Leist TP, Kohler M, Zinkernagel RM. Impaired generation of anti-viral cytotoxicity against lymphocytic choriomeningitis and vaccinia virus in mice treated with CD4-specific monoclonal antibody. Scand J Immunol. 30:1989;679-686.
28. Ahmed R, King CC, Oldstone MB. Virus-lymphocyte interaction: T cells of the helper subset are infected with lymphocytic choriomeningitis virus during persistent infection in vivo. J Virol. 61:1987;1571-1576.
29. Jamieson BD, Ahmed R. T cell memory. Long-term persistence of virus-specific cytotoxic T cells. J Exp Med. 169:1989;1993-2005.
30. Rahemtulla A, Kundig TM, Narendran A, Bachmann MF, Julius M, Paige CJ, Ohashi PS, Zinkernagel RM, Mak TW. Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice. Eur J Immunol. 24:1994;2213-2218.
31. Spriggs MK, Koller BH, Sato T, Morrissey PJ, Fanslow WC, Smithies O, Voice RF, Widmer MB, Maliszewski CR. Beta-2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci USA. 89:1992;6070-6074.
32. Mak TW, Rahemtulla A, Schilham M, Koh DR, Fung-Leung WP. Generation of mutant mice lacking surface expression of CD4 or CD8 gene targeting. Adv Exp Med Biol. 323:1992;73-77.
33. Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, Zinkernagel RM. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol. 68:1994;4700-4704.
34. Leung KN, Nash AA. Clonal analysis of T cell responses to herpes simplex virus: a HSV-specific, non cytolytic T cell clone displays specific helper activity for T cell response in vitro. Immunol Lett. 13:1986;55-61.
35. Leung KN, Nash AA, Sia DY, Wildy P. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone. Immunology. 53:1984;623-633.
36. Perng GC, Slanina SM, Ghiasi H, Nesburn AB, Wechsler SL. A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J Virol. 70:1996;2014-2018.
37. Perng GC, Ghiasi H, Slanina SM, Nesburn AB, Wechsler SL. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J Virol. 70:1996;976-984.